FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
We used a cellular system to elucidate the molecular determinants of the large immunophilin FK506-binding proteins (FKBP)51 and -52 for their action on the glucocorticoid receptor in mammalian cells. Increasing the levels of FKBP51 reduced the transcriptional activity of the receptor, as reported. Elevated levels of FKBP52 per se showed no effect but mitigated the inhibition of the receptor induced by FKBP51. We discovered that nuclear translocation of the glucocorticoid receptor was delayed by FKBP51. This correlates with the reduced interaction of FKBP51 with the motor protein dynein compared with FKBP52. From mutational analyses, we concluded that three features of the immunophilins are required for efficient receptor signaling in mammalian cells: hsp90 interaction, dynein association, and peptidylprolyl isomerase (PPIase) enzyme activity. The relevance of dynein for receptor function was substantiated by several experiments: 1) coexpression of dynamitin, which disrupts the transport complex and reduces receptor activity; 2) coexpression of the PPIase domain fragment of FKBP52, which is known to disrupt interaction of the receptor to dynein and reduce glucocorticoid receptor function, in contrast to the corresponding fragment of FKBP51; and 3) swapping of the PPIase domains FKBP51 and FKBP52, which reverses the respective activity. We concluded from our results that the mechanisms of the regulatory system FKBP51/FKBP52 discovered in yeast also operate in mammals to modulate hormone binding of the receptor. In addition, differential regulation of dynein association and nuclear translocation contributes to the effects of the two immunophilins on the glucocorticoid receptor in mammals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FKBP51 inhibits GR ligand binding, nuclear translocation and transcriptional activity, while FKBP52 potentiates each of these fundamental GR activities22–32.”
From Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor (2023) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FKBP52 stabilizes ligand-bound GR, resulting in enhanced ligand affinity, and facilitates rapid GR nuclear translocation on dynein22,24,25,65, allowing GR to proceed with dimerization and transcription activation.”
From Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor (2023) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As co-chaperones of Hsp90 (heat-shock protein 90), FKBP51 (FK506-binding protein of 51 kDa) and FKBP52 (FK506-binding protein of 52 kDa) act as antagonists in regulating the hormone affinity and nuclear transport of steroid receptor complexes.”
From Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52 (2014) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because the FKBPs and hsp90 are part of the same functional complex, it can be envisage that the disruption of the interaction between the FKBPs and the motor proteins should yield similar levels of inhibition of SHR retrotransport as that measured in the presence of hsp90 inhibitors. This was demonstrated when the receptor was “disconnected” from the transport machinery by overexpression of the P”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FKBP5, which encodes FK506 binding protein 5, a proximal protein regulator of GRs that has been shown to decrease GR affinity for its ligand cortisol, therefore disrupting the negative feedback loop in the HPA axis”
From The Epigenetics of Anxiety Pathophysiology: A DNA Methylation and Histone Modification Focused Review (2023) · cites this paper as Wochnik et al., 2005
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Self-citationSteroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Self-citationThe co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins
Connell, P., Ballinger, C. A., Jiang, J., Wu, Y., Thompson, L. J., Höhfeld, J., & Patterson, C. (2001) · Nature Cell Biology · doi:10.1038/35050618 · Cited by 997
Reduced levels of hsp90 compromise steroid receptor action in vivo
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S., & Yamamoto, K. R. (1990) · Nature · doi:10.1038/348166a0 · Cited by 787
Burkhardt, J. K., Echeverri, C. J., Nilsson, T., & Vallee, R. B. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.469 · Cited by 656
Steroid hormone receptors: an update
Beato, M. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.3.225 · Cited by 614
Research works printed but not linked: 4
- Pratt, 1997, Endocr. Rev., 18, 306
- Galigniana, 1998, Mol. Endocrinol., 12, 1903, 10.1210/mend.12.12.0204 · doi:10.1210/mend.12.12.0204 · Paper page
- Denny, 2000, Endocrinology, 141, 4107, 10.1210/endo.141.11.7785 · doi:10.1210/endo.141.11.7785 · Paper page
- Harrell, 2004, J. Biol. Chem.
Cited by
Items 101–200 of 640
The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling
Maiarù, M., Tochiki, K. K., Cox, M. B., Annan, L. V., Bell, C. G., Feng, X., Hausch, F., & Géranton, S. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3376 · Cited by 104
Differential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors
Schülke, J.-P., Wochnik, G. M., Lang-Rollin, I., Gassen, N. C., Knapp, R. T., Berning, B., Yassouridis, A., & Rein, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011717 · Cited by 105
Self-citationManeechotesuwan, K., Yao, X., Ito, K., Jazrawi, E., Usmani, O. S., Adcock, I. M., & Barnes, P. J. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000076 · Cited by 107
Multidomain Peptidyl Prolyl cis/trans Isomerases
Schiene‐Fischer, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.012 · Cited by 120
Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
Kageyama, K., Iwasaki, Y., & Daimon, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212242 · Cited by 137
Martinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
Unraveling the epigenetic landscape of depression: focus on early life stress
Torres-Berrío, A., Issler, O., Parise, E. M., & Nestler, E. J. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.4/enestler · Cited by 102
Age-Associated Epigenetic Upregulation of the FKBP5 Gene Selectively Impairs Stress Resiliency
Sabbagh, J. J., O'Leary, J. C., Blair, L. J., Klengel, T., Nordhues, B. A., Fontaine, S. N., Binder, E. B., & Dickey, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107241 · Cited by 101
Pereira, M. J., Palming, J., Svensson, M. K. E., Rizell, M., Dalenbäck, J., Hammar, M., Fall, T., Sidibeh, C. O., Svensson, P., & Eriksson, J. W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.015 · Cited by 112
FKBP5 polymorphism is associated with major depression but not with bipolar disorder
Szczepankiewicz, A., Leszczyńska-Rodziewicz, A., Pawlak, J., Narozna, B., Rajewska-Rager, A., Wilkosc, M., Zaremba, D., Maciukiewicz, M., & Twarowska-Hauser, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.002 · Cited by 100
Zaba, M., Kirmeier, T., Ionescu, I. A., Wollweber, B., Buell, D. R., Gall-Kleebach, D. J., Schubert, C. F., Novak, B., Huber, C., Köhler, K., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.02.005 · Cited by 101
Self-citationThe prospect of FKBP51 as a drug target
Schmidt, M. V., Paez‐Pereda, M., Holsboer, F., & Hausch, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200137 · Cited by 99
Self-citationGallo, L. I., Ghini, A. A., Piwien Pilipuk, G., & Galigniana, M. D. (2007) · Biochemistry · doi:10.1021/bi701372c · Cited by 99
Annett, S., Moore, G., & Robson, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107623 · Cited by 111
Molecular Dissection of Prethymic Progenitor Entry into the T Lymphocyte Developmental Pathway
Tydell, C. C., David-Fung, E.-S., Moore, J. E., Rowen, L., Taghon, T., & Rothenberg, E. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.421 · Cited by 99
Tozzi, L., Carballedo, A., Wetterling, F., McCarthy, H., O’Keane, V., Gill, M., Morris, D., Fahey, C., Meaney, J. F., & Frodl, T. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.170 · Cited by 108
Yang, X., Ewald, E. R., Huo, Y., Tamashiro, K. L., Salvatori, R., Sawa, A., Wand, G. S., & Lee, R. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.035 · Cited by 97
NF-κB Transcriptional Activity Is Modulated by FK506-binding Proteins FKBP51 and FKBP52
Erlejman, A. G., De Leo, S. A., Mazaira, G. I., Molinari, A. M., Camisay, M. F., Fontana, V., Cox, M. B., Piwien-Pilipuk, G., & Galigniana, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582882 · Cited by 97
Chaperoning steroidal physiology: Lessons from mouse genetic models of Hsp90 and its cochaperones
Sanchez, E. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.006 · Cited by 94
Thomas, M., Harrell, J. M., Morishima, Y., Peng, H.-M., Pratt, W. B., & Lieberman, A. P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl110 · Cited by 95
Epigenetic Risk Factors in PTSD and Depression
Raabe, F. J., & Spengler, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00080 · Cited by 93
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Zgajnar, N., De Leo, S., Lotufo, C., Erlejman, A., Piwien-Pilipuk, G., & Galigniana, M. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 94
Current concepts in glucocorticoid resistance
Yang, N., Ray, D. W., & Matthews, L. C. (2012) · Steroids · doi:10.1016/j.steroids.2012.05.007 · Cited by 105
Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives
Hertel, J., König, J., Homuth, G., der Auwera, S. V., Wittfeld, K., Pietzner, M., Kacprowski, T., Pfeiffer, L., Kretschmer, A., Waldenberger, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13927-7 · Cited by 105
Depression and antidepressants: molecular and cellular aspects
Lanni, C., Govoni, S. M., Lucchelli, A., & Boselli, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0055-x · Cited by 107
FKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92
“In contrast to FKBP51, the better-studied FKBP52 serves to promote the molecular activities of both GR and AR [23,27,28].”
BackgroundWestberry, J. M., Sadosky, P. W., Hubler, T. R., Gross, K. L., & Scammell, J. G. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.004 · Cited by 91
Fluorescent Probes to Characterise FK506‐Binding Proteins
Kozany, C., März, A., Kress, C., & Hausch, F. (2009) · ChemBioChem · doi:10.1002/cbic.200800806 · Cited by 91
Kohrt, B. A., Worthman, C. M., Ressler, K. J., Mercer, K. B., Upadhaya, N., Koirala, S., Nepal, M. K., Sharma, V. D., & Binder, E. B. (2015) · International Review of Psychiatry · doi:10.3109/09540261.2015.1020052 · Cited by 89
Jiang, W., Cazacu, S., Xiang, C., Zenklusen, J. C., Fine, H. A., Berens, M., Armstrong, B., Brodie, C., & Mikkelsen, T. (2008) · Neoplasia · doi:10.1593/neo.07929 · Cited by 88
“The dynamic formation of heterocomplexes with HSP90 and FKBP5/FKBP52 is required for modulating the translocation of steroid receptors, such as progesterone and glucocorticoid receptors to nucleus [9,10].”
BackgroundProlyl isomerases in gene transcription
Hanes, S. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.028 · Cited by 104
Quintá, H. R., Maschi, D., Gomez‐Sanchez, C., Piwien‐Pilipuk, G., & Galigniana, M. D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06970.x · Cited by 85
The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation
Chambraud, B., Belabes, H., Fontaine‐Lenoir, V., Fellous, A., & Baulieu, E. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-7667com · Cited by 85
Laukova, M., Alaluf, L. G., Serova, L. I., Arango, V., & Sabban, E. L. (2014) · Endocrinology · doi:10.1210/en.2014-1192 · Cited by 83
Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume
Holz, N. E., Buchmann, A. F., Boecker, R., Blomeyer, D., Baumeister, S., Wolf, I., Rietschel, M., Witt, S. H., Plichta, M. M., Meyer-Lindenberg, A., et al. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0729-5 · Cited by 82
“A promising candidate gene is FKBP5, which codes for a protein FK506 binding protein 5-51, a co-chaperone of the hsp90, and regulates the affinity of the GR for cortisol (Binder 2009; Denny et al. 2000; Wochnik et al. 2005).”
FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma
Romano, S., Xiao, Y., Nakaya, M., D'Angelillo, A., Chang, M., Jin, J., Hausch, F., Masullo, M., Feng, X., Romano, M. F., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv615 · Cited by 82
The role of DNA methylation in the pathophysiology and treatment of bipolar disorder
Fries, G. R., Li, Q., McAlpin, B., Rein, T., Walss-Bass, C., Soares, J. C., & Quevedo, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.010 · Cited by 81
Self-citationRegulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52)
Sivils, J. C., Storer, C. L., Galigniana, M. D., & Cox, M. B. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.010 · Cited by 81
Stanojević, M., & Dolenc, M. S. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04025-z · Cited by 104
Environmental Stressors and Epigenetic Control of the Hypothalamic-Pituitary-Adrenal Axis
Lee, R. S., & Sawa, A. (2014) · Neuroendocrinology · doi:10.1159/000369585 · Cited by 79
Klinger-König, J., Hertel, J., Van der Auwera, S., Frenzel, S., Pfeiffer, L., Waldenberger, M., Golchert, J., Teumer, A., Nauck, M., Homuth, G., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0319-6 · Cited by 78
Epigenetics of childhood trauma: Long term sequelae and potential for treatment
Thumfart, K. M., Jawaid, A., Bright, K., Flachsmann, M., & Mansuy, I. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.042 · Cited by 91
Galigniana, N. M., Ballmer, L. T., Toneatto, J., Erlejman, A. G., Lagadari, M., & Galigniana, M. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07775.x · Cited by 77
Lee, K., Thwin, A. C., Nadel, C. M., Tse, E., Gates, S. N., Gestwicki, J. E., & Southworth, D. R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.023 · Cited by 76
Glucocorticoid-regulated genes in eosinophilic esophagitis: A role for FKBP51
Caldwell, J. M., Blanchard, C., Collins, M. H., Putnam, P. E., Kaul, A., Aceves, S. S., Bouska, C. A., & Rothenberg, M. E. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.038 · Cited by 81
Functional principles and regulation of molecular chaperones
Dahiya, V., & Buchner, J. (2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2018.10.001 · Cited by 76
HNRC, Tatro, E. T., Everall, I. P., Masliah, E., Hult, B. J., Lucero, G., Chana, G., Soontornniyomkij, V., & Achim, C. L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9146-6 · Cited by 75
“FKBP52 functions as an adapter protein within the glucocorticoid receptor (GR) and HSP90 complex that links the hormone-bound receptor complex to the molecular motor dynein allowing for shuttling of the activated receptor complex to the nucleus (Wochnik et al. 2005).”
Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor
Noddings, C. M., Johnson, J. L., & Agard, D. A. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01128-y · Cited by 75
“FKBP52 stabilizes ligand-bound GR, resulting in enhanced ligand affinity, and facilitates rapid GR nuclear translocation on dynein 22,24,25,65 , allowing GR to proceed with dimerization and transcription activation.”
BackgroundGene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims
Pérez‐Ortiz, J. M., García‐Gutiérrez, M. S., Navarrete, F., Giner, S., & Manzanares, J. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.008 · Cited by 82
Diverse structures, functions and uses of FK506 binding proteins
Bonner, J. M., & Boulianne, G. L. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.013 · Cited by 82
Xu, J., Wang, R., Liu, Y., Liu, D., Jiang, H., & Pan, F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.010 · Cited by 78
Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., & Ising, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu087 · Cited by 74
“Indeed, oral administration of 1.5 mg of dex, a synthetic glucocorticoid with high affinity to the GR, resulted in a more than 5- to 10-fold stimulation of FKBP5 expression in peripheral blood cells after 3 hours (Menke et al., 2013).”
BackgroundInfluentialSelf-citationBaker, J. D., McMillan, I. O., Ospina, S. R., Gulick, D., & Blair, L. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010079 · Cited by 79
Banerjee, A., Periyasamy, S., Wolf, I. M., Hinds, T. D., Yong, W., Shou, W., & Sanchez, E. R. (2008) · Biochemistry · doi:10.1021/bi8011862 · Cited by 73
Focus on FKBP51: A molecular link between stress and metabolic disorders
Häusl, A. S., Balsevich, G., Gassen, N. C., & Schmidt, M. V. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.003 · Cited by 78
Ulirsch, J. C., Weaver, M. A., Bortsov, A. V., Soward, A. C., Swor, R. A., Peak, D. A., Jones, J. S., Rathlev, N. K., Lee, D. C., Domeier, R. M., et al. (2014) · Pain · doi:10.1016/j.pain.2014.07.025 · Cited by 73
Kitraki, E., Nalvarte, I., Alavian-Ghavanini, A., & Rüegg, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.028 · Cited by 72
Self-citationInterplay between diet-induced obesity and chronic stress in mice: potential role of FKBP51
Balsevich, G., Uribe, A., Wagner, K. V., Hartmann, J., Santarelli, S., Labermaier, C., & Schmidt, M. V. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0129 · Cited by 71
Dackis, M. N., Rogosch, F. A., Oshri, A., & Cicchetti, D. (2012) · Development and Psychopathology · doi:10.1017/s0954579412000673 · Cited by 71
Li, H., Su, P., Lai, T. K. Y., Jiang, A., Liu, J., Zhai, D., Campbell, C., Lee, F. H. F., Yong, W., Pasricha, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130363 · Cited by 80
Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels
Bailus, B. J., Scheeler, S. M., Simons, J., Sanchez, M. A., Tshilenge, K., Creus‐Muncunill, J., Naphade, S. B., Lopez‐Ramirez, A., Zhang, N., Madushani, K. L., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1904489 · Cited by 78
Grabe, H. J., Wittfeld, K., Van der Auwera, S., Janowitz, D., Hegenscheid, K., Habes, M., Homuth, G., Barnow, S., John, U., Nauck, M., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23123 · Cited by 67
Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapy
Minnetti, M., Hasenmajer, V., Pofi, R., Venneri, M. A., Alexandraki, K. I., & Isidori, A. M. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0066 · Cited by 70
Bortsov, A. V., Smith, J. E., Diatchenko, L., Soward, A. C., Ulirsch, J. C., Rossi, C., Swor, R. A., Hauda, W. E., Peak, D. A., Jones, J. S., et al. (2013) · Pain · doi:10.1016/j.pain.2013.04.037 · Cited by 69
Zhao, W., Zhong, L., Wu, J., Chen, L., Qing, K., Weigel-Kelley, K. A., Larsen, S. H., Shou, W., Warrington, K. H., & Srivastava, A. (2006) · Virology · doi:10.1016/j.virol.2006.04.042 · Cited by 69
The Role of Genes in Defining a Molecular Biology of PTSD
Yehuda, R., Koenen, K. C., Galea, S., & Flory, J. D. (2011) · Disease Markers · doi:10.1155/2011/185354 · Cited by 68
DNA methylation of FKBP5 and response to exposure-based psychological therapy
Roberts, S., Keers, R., Breen, G., Coleman, J. R. I., Jöhren, P., Kepa, A., Lester, K. J., Margraf, J., Scheider, S., Teismann, T., et al. (2019) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32650 · Cited by 67
Meijer, O. C., Buurstede, J. C., & Schaaf, M. J. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0625-2 · Cited by 77
Zong, Y., Zhu, S., Zhang, S., Zheng, G., Wiley, J. W., & Hong, S. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13477 · Cited by 77
Wilker, S., Pfeiffer, A., Kolassa, S., Elbert, T., Lingenfelder, B., Ovuga, E., Papassotiropoulos, A., de Quervain, D., & Kolassa, I.-T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.49 · Cited by 66
Denny, W. B., Prapapanich, V., Smith, D. F., & Scammell, J. G. (2005) · Endocrinology · doi:10.1210/en.2005-0027 · Cited by 66
Sarabdjitsingh, R. A., Meijer, O. C., Schaaf, M. J. M., & de Kloet, E. R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.048 · Cited by 70
WEI, K., XU, Y., ZHAO, Z., WU, X., DU, Y., SUN, J., YI, T., DONG, J., & LIU, B. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2591 · Cited by 65
Rein, T. (2016) · BioEssays · doi:10.1002/bies.201600050 · Cited by 64
Self-citationEvaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Gaali, S., Kress, C., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201746x · Cited by 64
Molecular Cochaperones: Tumor Growth and Cancer Treatment
Calderwood, S. K. (2013) · Scientifica · doi:10.1155/2013/217513 · Cited by 68
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Gassen, N. C., Hartmann, J., Zannas, A. S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L. K., Wagner, K. V., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.38 · Cited by 62
Self-citationWagner, K. V., Marinescu, D., Hartmann, J., Wang, X., Labermaier, C., Scharf, S. H., Liebl, C., Uhr, M., Holsboer, F., Müller, M. B., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.150 · Cited by 66
Self-citationRao, S., Yao, Y., Ryan, J., Li, T., Wang, D., Zheng, C., Xu, Y., & Xu, Q. (2016) · Scientific Reports · doi:10.1038/srep32687 · Cited by 62
FKBP51 modulates steroid sensitivity and NFκB signalling: A novel anti‐inflammatory drug target
Kästle, M., Kistler, B., Lamla, T., Bretschneider, T., Lamb, D., Nicklin, P., & Wyatt, D. (2018) · European Journal of Immunology · doi:10.1002/eji.201847699 · Cited by 61
Cox, M. B., Riggs, D. L., Hessling, M., Schumacher, F., Buchner, J., & Smith, D. F. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0547 · Cited by 60
Zheng, D., Sabbagh, J. J., Blair, L. J., Darling, A. L., Wen, X., & Dickey, C. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.727941 · Cited by 61
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 66
Zong, S., Jiao, Y., Liu, X., Mu, W., Yuan, X., Qu, Y., Xia, Y., Liu, S., Sun, H., Wang, L., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03857-8 · Cited by 71
Huang, M., Schwandt, M. L., Chester, J. A., Kirchhoff, A. M., Kao, C., Liang, T., Tapocik, J. D., Ramchandani, V. A., George, D. T., Hodgkinson, C. A., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.55 · Cited by 64
Lee, T.-Y., Hsu, J. B., Lin, F., Chang, W., Hsu, P., & Huang, H. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21569 · Cited by 66
Jochems, J., Teegarden, S. L., Chen, Y., Boulden, J., Challis, C., Ben-Dor, G. A., Kim, S. F., & Berton, O. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.036 · Cited by 58
Martín‐Blanco, A., Ferrer, M., Soler, J., Arranz, M. J., Vega, D., Calvo, N., Elices, M., Sánchez‐Mora, C., Iris Garcia-martinez, A., Salazar, J., et al. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0612-2 · Cited by 77
Malekpour, M., Shekouh, D., Safavinia, M. E., Shiralipour, S., Jalouli, M., Mortezanejad, S., Azarpira, N., & Ebrahimi, N. D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1182345 · Cited by 85
Kamble, P. G., Hetty, S., Vranic, M., Almby, K. E., Castillejo-López, C., Abalo, X. M., Pereira, M. J., & Eriksson, J. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-67293-y · Cited by 65
Kollara, A., & Brown, T. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1000-y · Cited by 58
Interactions of the mineralocorticoid receptor – Within and without
Yang, J., & Fuller, P. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.001 · Cited by 63
Toneatto, J., Guber, S., Charó, N. L., Susperreguy, S., Schwartz, J., Galigniana, M., & Piwien-Pilipuk, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.125799 · Cited by 55
Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy
Adachi, H., Waza, M., Katsuno, M., Tanaka, F., Doyu, M., & Sobue, G. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00830.x · Cited by 56
Nicolaides, N. C., & Charmandari, E. (2017) · Hormones · doi:10.14310/horm.2002.1728 · Cited by 52
Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation
Tranguch, S. L., Smith, D. F., & Dey, S. K. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60655-4 · Cited by 60
Barfield, E. T., & Gourley, S. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.015 · Cited by 53
Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice
Criado-Marrero, M., Gebru, N. T., Blazier, D. M., Gould, L. A., Baker, J. D., Beaulieu-Abdelahad, D., & Blair, L. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01159-w · Cited by 46
Minelli, A., Maffioletti, E., Cloninger, C. R., Magri, C., Sartori, R., Bortolomasi, M., Congiu, C., Bignotti, S., Segala, M., Giacopuzzi, M., et al. (2013) · Depression and Anxiety · doi:10.1002/da.22158 · Cited by 52
Macedo, J. A., Hesse, J., Turner, J. D., Meyer, J., Hellhammer, D. H., & Muller, C. P. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.012 · Cited by 62
Metadata
- Authors
- Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T.
- Affiliations
- Max Planck Society (DE)
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Rein, Theo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 280
- Issue
- 6
- Pages
- 4609-4616
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1974793156
- Semantic Scholar
- ad296b827a0059269b259a30f785886a9e04c88e
- Cited by
- 638
- References
- 52
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 34 · 2023: 43 · 2022: 34 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 32 · 2017: 28 · 2016: 41 · 2015: 32 · 2014: 40 · 2013: 29 · 2012: 36
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5714 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- FKBP51, FKBP52, immunophilins, glucocorticoid receptor, dynein, nuclear translocation, HSP90, peptidylprolyl isomerase, dynamitin, transcriptional regulation, receptor signaling, hormone binding
- MeSH terms
- Tacrolimus Binding Protein 5, Animals, beta-Galactosidase, Cell Line, Cell Nucleus, DNA Mutational Analysis, Dyneins, Glucocorticoids, HeLa Cells, Humans, Luciferases, Plasmids, Protein Binding, Receptors, Glucocorticoid, Time Factors, Transfection, Tyrosine, Blotting, Western, Tacrolimus, Protein Structure, Tertiary, HSP90 Heat-Shock Proteins, Peptidylprolyl Isomerase, Immunophilins, Reverse Transcriptase Polymerase Chain Reaction, Active Transport, Cell Nucleus, Tacrolimus Binding Proteins, Cell Line, Tumor, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.